Terragen Holdings Ltd (TGH) AI Stock Analysis

• Market Cap: AU$14.52M
• Dividend Yield: N/A
• Average Volume (3M): 27.47K
• Price to Earnings (P/E): ―
• Beta (1Y): -1.04
• Revenue Growth: -24.42%
• EPS Growth: -2.30%
• Country: AU
• Employees: N/A
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Agricultural Inputs
• EPS (TTM): >-0.01
• Shares Outstanding: 631,271,500
• 10 Day Avg. Volume: 51,927
• 30 Day Avg. Volume: 27,470
• PEG Ratio: 0.97
• Price to Book (P/B): 1.27
• Price to Sales (P/S): 5.15
• P/FCF Ratio: -2.74
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 42 Neutral
• Price Target: AU$0.02 ▲(10.00% Upside)
• Action: Upgraded Date: 03/04/26
• Date: Action: Upgraded 03/04/26

The score is primarily constrained by weak financial performance (declining revenue, ongoing losses, and negative operating/free cash flow). Technicals are only mildly stabilizing with neutral RSI but negative MACD, and valuation remains challenged due to a negative P/E and no dividend support.

Positive Factors

Conservative leverage

A low debt-to-equity ratio of 0.11 provides durable financial flexibility, reducing solvency and refinancing risk. Over a 2–6 month horizon this conservative leverage supports operations, allows strategic optionality, and cushions the company while it works to restore profitability.

Stable capital structure

A stable equity ratio signals a solid capital base that can absorb short-term shocks and reduces the need for urgent dilutive financing. This structural stability helps preserve creditor and supplier confidence and supports continuity of operations as management addresses growth and margin pressures.

Improving free cash flow alignment

Slight improvement in free cash flow growth and an FCF-to-net-income ratio above 1 indicate cash generation is beginning to better reflect accounting results. While cash flow remains weak, this trend is a durable positive sign for reducing cash burn and supporting multi-month recovery initiatives.

Negative Factors

Declining revenue

A persistent revenue decline (reported at -6.72%) weakens scale economics and reduces operating leverage. Over several months this constrains margin recovery, limits reinvestment in growth initiatives, and heightens the risk that fixed costs will continue to depress profitability absent a sustained demand turnaround.

Negative profitability margins

Negative net and EBIT margins signal the core business is loss-making, producing no excess earnings to fund growth or returns. Structurally, sustained negative margins erode equity and restrict reinvestment, making it harder to restore competitive positioning without substantive cost or revenue improvements.

Weak operating cash generation

Negative operating cash flow indicates core operations are not self-funding, forcing reliance on external financing or asset sales. Even with slight FCF improvement, persistent negative operating cash flow undermines liquidity, limits capital investments, and elevates refinancing and execution risk over the medium term.

Terragen Holdings Ltd Business Overview & Revenue Model

Company Description

Terragen Holdings Limited engages in the research, development, production, and sale of biological products for agriculture sector in Australia and New Zealand. It offers Mylo, an animal feed supplement; and Great Land, a liquid biological soil conditioner that improves soil characteristics. The company was incorporated in 1996 and is based in Coolum Beach, Australia.

How the Company Makes Money

Terragen Holdings generates revenue through the sale of its agricultural products, including microbial inoculants and specialty fertilizers. The company targets farmers, agricultural producers, and distributors, providing them with solutions that enhance crop productivity while adhering to sustainable practices. Key revenue streams come from direct sales, partnerships with agricultural distributors, and possibly licensing agreements related to its proprietary technologies. Additionally, TGH may benefit from collaborations with research institutions or agricultural organizations, which can enhance product development and market reach, ultimately contributing to its earnings.

Terragen Holdings Ltd Financial Statement Overview

Summary

Weak fundamentals: revenue declined (-6.72%), profitability is pressured with negative net and EBIT margins, and cash generation is poor with negative operating and free cash flow. A low debt-to-equity ratio (0.11) provides some balance-sheet stability, but negative ROE underscores ongoing losses.

Income Statement

Terragen Holdings Ltd has experienced declining revenues over the past year, with a negative revenue growth rate of -6.72%. The company is facing significant profitability challenges, as indicated by negative net profit margins and EBIT margins. The gross profit margin has also decreased significantly from previous years, indicating pressure on cost management. Overall, the income statement reflects a company struggling with profitability and growth.

Balance Sheet

The balance sheet of Terragen Holdings Ltd shows a relatively low debt-to-equity ratio of 0.11, indicating conservative leverage. However, the return on equity is negative, reflecting ongoing losses and inefficiencies in generating returns for shareholders. The equity ratio is stable, suggesting a solid capital structure, but the negative ROE highlights significant profitability issues.

Cash Flow

Terragen Holdings Ltd's cash flow statement reveals negative operating cash flow and free cash flow, although there is a slight improvement in free cash flow growth. The operating cash flow to net income ratio is negative, indicating that the company is not generating sufficient cash from its operations to cover its net losses. The free cash flow to net income ratio is slightly above 1, suggesting some alignment between cash flow and accounting profits, but overall cash flow performance remains weak.

Breakdown	TTM	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021
Income Statement
Total Revenue	1.38M	1.62M	2.14M	3.28M	2.89M	3.65M
Gross Profit	583.15K	792.23K	2.06M	3.21M	2.62M	3.19M
EBITDA	-3.82M	-4.68M	-3.50M	-3.46M	-5.67M	-6.13M
Net Income	-3.20M	-3.72M	-3.01M	-3.23M	-5.41M	-6.10M
Balance Sheet
Total Assets	5.84M	8.12M	6.95M	6.35M	9.22M	14.72M
Cash, Cash Equivalents and Short-Term Investments	2.82M	4.81M	4.54M	4.17M	6.67M	11.64M
Total Debt	483.87K	735.45K	542.23K	239.37K	332.26K	357.96K
Total Liabilities	1.07M	1.55M	1.63M	1.27M	1.46M	1.70M
Stockholders Equity	4.78M	6.57M	5.32M	5.08M	7.76M	13.02M
Cash Flow
Free Cash Flow	-3.59M	-3.03M	-2.35M	-2.91M	-4.97M	-4.93M
Operating Cash Flow	-3.55M	-3.03M	-2.32M	-2.81M	-4.80M	-4.52M
Investing Cash Flow	-661.04K	-682.43K	-132.93K	-35.20K	-118.20K	-408.02K
Financing Cash Flow	932.53K	3.87M	2.82M	351.00K	-52.70K	194.92K

Terragen Holdings Ltd Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.02
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:TGH, the sentiment is Negative. The current price of 0.02 is equal to the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 46.15 is Neutral, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:TGH.

Terragen Holdings Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
ABX	52 Neutral	AU$27.21M	-6.47	-25.50%	―	-100.00%	-182.93%
OLY	46 Neutral	AU$7.91M	-1.39	-217.79%	―	―	43.46%
RLF	43 Neutral	AU$27.17M	-3.77	-41.21%	―	140.94%	88.59%
CDT	43 Neutral	AU$10.40M	-1.09	-390.08%	―	―	19.94%
TGH	42 Neutral	AU$14.52M	-3.65	-62.66%	―	-24.42%	-2.30%

Terragen Holdings Ltd Corporate Events

Terragen trial shows biostimulant lifts maize silage yields and margins

Terragen Holdings has released an independent commercial-scale assessment showing its Great Land Plus biostimulant increased maize silage yields by up to 12 percent over standard grower practice. The trial, conducted by on-farm trial specialist Laconik in New South Wales, found the recommended 4 L/ha application rate outperformed lower doses and combinations with kelp extract.

Using prevailing Australian silage maize values, Terragen estimated the yield uplift equates to about $1,100 in additional gross revenue per hectare. With total treatment and application costs of $55 per hectare, the company calculates a potential return on investment of up to 20 times, reinforcing GLP’s positioning as a cost-effective tool for boosting productivity and supporting soil health.

The 13 replicated data sets across multiple blocks delivered statistically significant results for the 4 L/ha GLP treatment, while lower rates and kelp combinations showed no significant advantage over untreated controls. Terragen says the findings should give growers greater confidence to adopt GLP in silage maize production and potentially improve farm profitability under comparable conditions.

The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.

Terragen Sets March 2026 Virtual General Meeting and Shifts to Digital Meeting Materials

Terragen Holdings Limited has called a virtual general meeting for shareholders to be held on 25 March 2026 at 10:00am Melbourne time, with access provided via an online meeting link and associated digital materials. The company is moving to primarily electronic distribution of its Notice of General Meeting and Explanatory Memorandum, in line with Corporations Act provisions, while still allowing investors to request hard copies or seek assistance from the company secretary or share registry.

Shareholders are being strongly encouraged to lodge directed proxy forms by 23 March 2026 and to submit questions ahead of the meeting so management can prepare responses. The arrangements underscore Terragen’s focus on increasing digital engagement and administrative efficiency in its shareholder communications, which may facilitate broader participation while reducing reliance on physical documentation.

The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.

Terragen Plans Major Share Placement of Nearly 192 Million Shares

Terragen Holdings Limited has lodged a notice with the ASX for a proposed placement of up to 191,927,526 new fully paid ordinary shares, to be issued on 30 March 2026, under its existing listing framework. The sizeable equity issuance, once completed, will materially expand the company’s share base and is expected to provide additional capital for its operations or strategic initiatives, with implications for existing shareholders through potential dilution and for the market through an increased free float in TGH securities.

The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.

Terragen Plans Major Equity Placement of Over 126 Million Shares

Terragen Holdings Ltd has announced a proposed placement of up to 126,254,293 new fully paid ordinary shares, to be issued on 16 February 2026, subject to ASX processes. The capital raising signals a significant equity issuance that could alter the company’s capital structure and shareholder dilution profile, positioning Terragen to access new funding for its operations or strategic initiatives while investors await further detail on pricing and use of proceeds.

The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.

Terragen Shares Halted Ahead of Material Institutional Placement

Terragen Holdings Limited has requested and been granted a trading halt on its shares on the ASX as it prepares to announce a material institutional placement, signalling an imminent capital raise. The halt will remain in place until either the start of trading on 6 February 2026 or the release of the capital-raising announcement, indicating that Terragen is seeking to strengthen its balance sheet and potentially fund further growth or operational initiatives, with near‑term implications for existing shareholders and the company’s capital structure.

The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.

Terragen Accelerates Ruminant Probiotic Rollout Amid Global Expansion Push

Terragen reported strong momentum in its Terragen Probiotic for Ruminants (TPR) business, highlighted by a large-scale assessment with Mort & Co at Australia’s largest single-site beef feedlot covering more than 10,000 head, alongside an 87% quarter-on-quarter increase in TPR sales since its April 2025 launch. The company advanced global market access with regulatory trial permits in Canada, ongoing approvals in Brazil and Canada, and negotiations with a global nutrition group for North American manufacturing and distribution, while drought and weak dairy trading conditions weighed on total sales; meanwhile, its Great Land Plus soil product delivered leading tomato yields in commercial trials, companion animal formulations moved into pilot-scale production, and lamb feedlot usage of TPR expanded through confirmed ongoing dosing commitments and new producer-led demonstrations.

The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.

Terragen Options Lapse, Easing Potential Share Dilution

Terragen Holdings Ltd, listed on the ASX under code TGH, has reported a change in its issued capital structure. The company has confirmed that 5 million options, previously on issue and exercisable at A$1.00 with an expiry date of 4 December 2025, have lapsed unexercised as of that date. The expiry of these options without conversion reduces the potential future dilution of existing shareholders and marginally simplifies Terragen’s capital structure, although it does not directly affect current issued share capital or provide new funding to the company.

The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.

Terragen Holdings Options Lapse, Trimming Potential Future Dilution

Terragen Holdings Limited has announced the expiry of 2,000,000 unexercised options (ASX code TGHAU) that were due to expire on 4 December 2025 with an exercise price of A$0.50. The lapse of these options slightly reduces the company’s potential future share dilution but has no immediate impact on its existing issued capital, reflecting a routine adjustment to its capital structure rather than a change in underlying operations.

The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.

Terragen Options Lapse as 1 Million Unexercised Securities Expire

Terragen Holdings Limited has confirmed the expiry of a tranche of unexercised options listed on the ASX. The company reported that 1,000,000 options, exercisable at A$0.25 and due to expire on 4 December 2025 under the code TGHAT, have lapsed without being converted into shares, resulting in a reduction of potential future dilution for existing shareholders but no immediate change to the company’s issued capital.

The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.

Terragen Options Lapse as 1 Million Unexercised Securities Expire

Terragen Holdings Limited has confirmed the expiry of a tranche of unexercised options listed on the ASX. The company reported that 1,000,000 options, exercisable at A$0.25 and due to expire on 4 December 2025 under the code TGHAT, have lapsed without being converted into shares, resulting in a reduction of potential future dilution for existing shareholders but no immediate change to the company’s issued capital.

The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.

Terragen Holdings Boosts R&D Efforts with Tax Incentive

Terragen Holdings Limited has received a $989,242 R&D tax incentive from the Australian Taxation Office for the 2024/2025 financial year, which will bolster their cash reserves and support ongoing commercialisation and development efforts. This incentive underscores Terragen’s commitment to advancing its position in the agricultural industry by investing in innovative solutions that enhance productivity and environmental outcomes, benefiting stakeholders and contributing to agricultural decarbonisation.

The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.